Inosine - PolysanAlternative Names: Riboxinum; Runihol
Latest Information Update: 18 Oct 2016
At a glance
- Originator POLYSAN
- Class Purine nucleosides; Ribonucleosides; Small molecules
- Mechanism of Action Cytokine modulators; Inflammation mediator modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Liver disorders
Most Recent Events
- 01 Jun 2016 Phase-II clinical trials in Liver disorders in Russia (PO)